Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Maryellen Noreika"


3 mentions found


Foster City, California-based Gilead collaborated with the CDC in the mid-2000s to test if Truvada could prevent HIV as well as treat it. The government received four patents for HIV prevention drug regimens that CDC researchers invented. Its lawsuit claims the patents also cover Gilead's pre-exposure prophylaxis (PrEP) drug regimen for lowering HIV infection risk. The U.S. Food and Drug Administration approved Gilead's Truvada for HIV prevention in 2012 and approved its related drug Descovy for the same purpose in 2019. Descovy, which earned Gilead over $1.8 billion last year, is its fourth-best selling drug behind the HIV drugs Biktarvy and Genvoya and COVID-19 treatment Veklury.
An American flag waves outside the U.S. Department of Justice Building in Washington, U.S., December 15, 2020. REUTERS/Al DragoWASHINGTON, Sept 26 (Reuters) - The U.S. Justice Department said on Monday it would appeal a judge's ruling that U.S. Sugar Corp's plans to buy rival Imperial Sugar Co was legal under antitrust law, according to a court filing. Judge Maryellen Noreika of the U.S. District Court for Delaware had ruled for the companies on Friday, rejecting the government's request that she stop the deal from going forward. read moreAsked about the government's indication that it would appeal, U.S. Sugar said: "We look forward to expeditiously closing this acquisition as planned." Register now for FREE unlimited access to Reuters.com RegisterReporting by Diane Bartz and Anirudh Saligrama; Editing by Kim Coghill and Rashmi AichOur Standards: The Thomson Reuters Trust Principles.
A federal judge Friday ruled U.S. Sugar can proceed with its planned purchase of rival Imperial Sugar, rejecting a Justice Department antitrust challenge to the deal. U.S. District Judge Maryellen Noreika in Delaware didn’t immediately release her full opinion, citing a need to protect confidential business information, but she released a one-page public judgment that said the acquisition wouldn’t violate federal antitrust law.
Total: 3